Insmed to Stop Supplying IPLEX to New Patients

In the interest of treating patients already receiving IPLEX, executives at Insmed have halted the distribution to any new patients. Citing an insurmountable financial burden, Insmed has decided to stop production of IPLEX, so the remaining stock will go to treating patients already on the drug.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail